Alzheimer's drug slowed progression of the disease in Phase 3 trial
Japanese drugmaker Eisai said cognitive decline slowed over 18 months in patients who received the drug, called lecanemab.
#alzheimer #drug #eisai
Alzheimer's drug slowed progression of the disease in Phase 3 trial
Upworthy
0 shares
1 views
You might like
Related news coverage
New Alzheimer's drug shows promising results in trial
Deutsche Welle
Preliminary results of a phase three Alzheimer's drug trial appeared to slow progression of the disease.
-
New Alzheimer's drug slows cognitive decline by 27%, clinical trial finds
Business Insider
-
Alzheimer's drug slowed progression of disease in late-stage study, drugmakers say
USATODAY.com
-
Promising MND drug helps slow disease progression and benefits patients physically
Science Daily
-
US Clinical Trial Evaluating Antiviral For Monkeypox Begins
Eurasia Review